Latest news
Clinuvel Pharmaceuticals (OTC: CLVLF) maps vitiligo trial benchmarks and plans - Stock TitanStock Titan · Thu, 30 Jul 2026 10:10:30 GMTClinuvel steps up vitiligo push as SCENESSE data and North American rollout near - TipRanksTipRanks · Wed, 29 Jul 2026 23:46:50 GMTOne Healthcare Stock with Room for an Upside– Clinuvel Pharmaceuticals Limited - KalkineKalkine · Tue, 28 Jul 2026 19:52:42 GMTCLINUVEL Advances SCENESSE® Vitiligo Programme With CUV105 Topline Results Expected December 2026 - KalkineKalkine · Tue, 28 Jul 2026 07:00:00 GMT